{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:43:54Z","timestamp":1789983834271,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T00:00:00Z","timestamp":1491523200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-1908-5","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T07:50:52Z","timestamp":1491551452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The efficacy of sodium benzoate as an adjunctive treatment in early psychosis - CADENCE-BZ: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"18","author":[{"given":"Alex","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Dark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Hatherill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Stathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukanta","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Bruxner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Beckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cadence Working","family":"Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"issue":"Suppl 1","key":"1908_CR1","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1093\/schbul\/sbl029","volume":"32","author":"SM Couture","year":"2006","unstructured":"Couture SM, Penn DL, Roberts DL. The functional significance of social cognition in schizophrenia: a review. Schizophr Bull. 2006;32 Suppl 1:S44\u201363.","journal-title":"Schizophr Bull."},{"issue":"11","key":"1908_CR2","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1111\/j.1742-1241.2009.02191.x","volume":"63","author":"J Karagianis","year":"2009","unstructured":"Karagianis J, Novick D, Pecenak J, et al. Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients. Int J Clin Pract. 2009;63(11):1578\u201388.","journal-title":"Int J Clin Pract"},{"issue":"12","key":"1908_CR3","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209\u201323.","journal-title":"N Engl J Med"},{"issue":"9","key":"1908_CR4","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1517\/14728222.2014.934225","volume":"18","author":"K Hashimoto","year":"2014","unstructured":"Hashimoto K. Targeting of NMDA receptors in new treatments for schizophrenia. Expert Opin Ther Targets. 2014;18(9):1049\u201363.","journal-title":"Expert Opin Ther Targets"},{"issue":"5","key":"1908_CR5","doi-asserted-by":"publisher","first-page":"522","DOI":"10.2174\/138161210790361452","volume":"16","author":"GE Tsai","year":"2010","unstructured":"Tsai GE, Lin PY. Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis. Curr Pharm Des. 2010;16(5):522\u201337.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"1908_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.biopsych.2005.06.032","volume":"59","author":"GE Tsai","year":"2006","unstructured":"Tsai GE, Yang P, Chang YC, Chong MY. D-alanine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry. 2006;59(3):230\u20134.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"1908_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.bbrc.2007.01.181","volume":"355","author":"T Kawazoe","year":"2007","unstructured":"Kawazoe T, Tsuge H, Imagawa T, Aki K, Kuramitsu S, Fukui K. Structural basis of D-DOPA oxidation by D-amino acid oxidase: alternative pathway for dopamine biosynthesis. Biochem Biophys Res Commun. 2007;355(2):385\u201391.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"1908_CR8","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1016\/j.febslet.2006.03.045","volume":"580","author":"G Molla","year":"2006","unstructured":"Molla G, Sacchi S, Bernasconi M, Pilone MS, Fukui K, Polegioni L. Characterization of human D-amino acid oxidase. FEBS Lett. 2006;580(9):2358\u201364.","journal-title":"FEBS Lett"},{"issue":"2","key":"1908_CR9","first-page":"269","volume":"77","author":"CE Ganote","year":"1974","unstructured":"Ganote CE, Peterson DR, Carone FA. The nature of D-serine\u2013induced nephrotoxicity. Am J Pathol. 1974;77(2):269\u201382.","journal-title":"Am J Pathol"},{"issue":"11","key":"1908_CR10","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1021\/tx0500326","volume":"18","author":"M Maekawa","year":"2005","unstructured":"Maekawa M, Okamura T, Kasai N, Hori Y, Summer KH, Konno R. D-amino-acid oxidase is involved in D-serine-induced nephrotoxicity. Chem Res Toxicol. 2005;18(11):1678\u201382.","journal-title":"Chem Res Toxicol"},{"issue":"12","key":"1908_CR11","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1021\/jm800200u","volume":"51","author":"D Ferraris","year":"2008","unstructured":"Ferraris D, Duvall B, Ko YS, et al. Synthesis and biological evaluation of D-amino acid oxidase inhibitors. J Med Chem. 2008;51(12):3357\u20139.","journal-title":"J Med Chem"},{"issue":"12","key":"1908_CR12","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1001\/jamapsychiatry.2013.2159","volume":"70","author":"HY Lane","year":"2013","unstructured":"Lane HY, Lin CH, Green MF, et al. Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor. JAMA Psychiat. 2013;70(12):1267\u201375.","journal-title":"JAMA Psychiat"},{"issue":"9","key":"1908_CR13","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.biopsych.2013.08.010","volume":"75","author":"CH Lin","year":"2014","unstructured":"Lin CH, Chen PK, Chang YC, et al. Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial. Biol Psychiatry. 2014;75(9):678\u201385.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1908_CR14","doi-asserted-by":"publisher","first-page":"E50","DOI":"10.1176\/appi.neuropsych.12030056","volume":"25","author":"CH Lai","year":"2013","unstructured":"Lai CH. Sodium benzoate, a D-amino acid oxidase inhibitor, increased volumes of thalamus, amygdala, and brainstem in a drug-naive patient with major depression. J Neuropsychiatry Clin Neurosci. 2013;25(1):E50\u20131.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"1908_CR15","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.biopsych.2011.10.034","volume":"71","author":"CH Lai","year":"2012","unstructured":"Lai CH, Lane HY, Tsai GE. Clinical and cerebral volumetric effects of sodium benzoate, a D-amino acid oxidase inhibitor, in a drug-naive patient with major depression. Biol Psychiatry. 2012;71(4):e9\u201310.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"1908_CR16","first-page":"E7","volume":"25","author":"YC Hou","year":"2013","unstructured":"Hou YC, Lai CH. A kind of D-amino acid oxidase inhibitor, sodium benzoate, might relieve panic symptoms in a first-episode, drug-naive panic-disorder patient. J Neuropsychiatry Clin Neurosci. 2013;25(2):E7\u20138.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"1908_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5694\/mja14.00914","volume":"202","author":"PD McGorry","year":"2015","unstructured":"McGorry PD. Australian Early Psychosis Research Network: national collaboration, international competitive advantage. Med J Aust. 2015;202(4):170\u20131.","journal-title":"Med J Aust"},{"issue":"1-3","key":"1908_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2010.02.1071","volume":"119","author":"SM Francey","year":"2010","unstructured":"Francey SM, Nelson B, Thompson A, et al. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Schizophr Res. 2010;119(1-3):1\u201310.","journal-title":"Schizophr Res"},{"issue":"4","key":"1908_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF02263659","volume":"4","author":"ML Batshaw","year":"1981","unstructured":"Batshaw ML, Brusilow SW. Evidence of lack of toxicity of sodium phenylacetate and sodium benzoate in treating urea cycle enzymopathies. J Inherit Metab Dis. 1981;4(4):231.","journal-title":"J Inherit Metab Dis"},{"issue":"1-4","key":"1908_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000469211","volume":"38","author":"ML Batshaw","year":"1987","unstructured":"Batshaw ML, Monahan PS. Treatment of urea cycle disorders. Enzyme. 1987;38(1-4):242\u201350.","journal-title":"Enzyme"},{"issue":"5","key":"1908_CR21","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0022-3476(83)80259-5","volume":"102","author":"TP Green","year":"1983","unstructured":"Green TP, Marchessault RP, Freese DK. Disposition of sodium benzoate in newborn infants with hyperammonemia. J Pediatr. 1983;102(5):785\u201390.","journal-title":"J Pediatr"},{"key":"1908_CR22","volume-title":"Summary of evaluations perfomed by the Joint FAO\/WHO Expert Committee on Food Addivites (JECFA)","author":"Food and Agriculture Organization of the United Nations World Health Organization (FAO\/WHO)","year":"1994","unstructured":"Food and Agriculture Organization of the United Nations World Health Organization (FAO\/WHO). Summary of evaluations perfomed by the Joint FAO\/WHO Expert Committee on Food Addivites (JECFA). Washington: International Life Sciences Institute; 1994."},{"key":"1908_CR23","volume-title":"The Food Chemical News guide to the current status of food additivies and color additives","author":"DL Rothschild Jr","year":"1990","unstructured":"Rothschild Jr DL. The Food Chemical News guide to the current status of food additivies and color additives. Washington: Food and Chemical News; 1990."},{"key":"1908_CR24","unstructured":"World Health Organization. Toxicological evaluation of certain food additives and contaminants. WHO Food Additives Series, No. 35, Geneva: 1996."},{"key":"1908_CR25","unstructured":"Safety evaluation of certain food additives. WHO Food Additives Series, No. 42, Geneva: 1999."},{"key":"1908_CR26","first-page":"47","volume":"96","author":"H Onodera","year":"1978","unstructured":"Onodera H, Ogiu T, Matsuoka C, et al. Studies on effects of sodium benzoate on fetuses and offspring of Wistar rats. Eisei Shikensho Hokoku. 1978;96:47\u201355.","journal-title":"Eisei Shikensho Hokoku."},{"issue":"6","key":"1908_CR27","first-page":"506","volume":"38","author":"AW Chan","year":"2015","unstructured":"Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Rev Panam Salud Publica. 2015;38(6):506\u201314.","journal-title":"Rev Panam Salud Publica"},{"key":"1908_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Gotzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346, e7586.","journal-title":"BMJ."},{"key":"1908_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1471-244X-11-113","volume":"11","author":"M Obermeier","year":"2011","unstructured":"Obermeier M, Schennach-Wolff R, Meyer S, et al. Is the PANSS used correctly? A systematic review. BMC Psychiatry. 2011;11:113.","journal-title":"BMC Psychiatry."},{"issue":"11","key":"1908_CR30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/00005053-199211000-00007","volume":"180","author":"M Bell","year":"1992","unstructured":"Bell M, Milstein R, Beam-Goulet J, Lysaker P, Cicchetti D. The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability, and predictive validity. J Nerv Ment Dis. 1992;180(11):723\u20138.","journal-title":"J Nerv Ment Dis"},{"key":"1908_CR31","volume-title":"Benzoic Acid and Sodium Benzoate","author":"World Health Organization","year":"2000","unstructured":"World Health Organization. Benzoic Acid and Sodium Benzoate. Geneva: World Health Organization; 2000."},{"issue":"3-4","key":"1908_CR32","first-page":"148","volume":"15","author":"World Health Organization","year":"2001","unstructured":"World Health Organization. Recommened inn list 46 international nonproprietary names for pharmaceutical substances. WHO Drug Information. 2001;15(3-4):148\u201387.","journal-title":"WHO Drug Information."},{"issue":"1-2","key":"1908_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0378-4347(92)80300-F","volume":"582","author":"A Hashimoto","year":"1992","unstructured":"Hashimoto A, Nishikawa T, Oka T, Takahashi K, Hayashi T. Determination of free amino acid enantiomers in rat brain and serum by high-performance liquid chromatography after derivatization with N-tert.-butyloxycarbonyl-L-cysteine and o-phthaldialdehyde. J Chromatogr. 1992;582(1-2):41\u20138.","journal-title":"J Chromatogr"},{"key":"1908_CR34","unstructured":"International Council of Beverages Associations. ICBA guidance document to mitigate the potential for benzene formation in beverages: UNESDA - Union of European Beverages Associations, 2005\u20132006."},{"issue":"1","key":"1908_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/0004867413515059","volume":"48","author":"JJ McGrath","year":"2014","unstructured":"McGrath JJ. The John Cade Fellowship: Modifiable risk factors for serious mental illness. Aust N Z J Psychiatry. 2014;48(1):13\u20136.","journal-title":"Aust N Z J Psychiatry"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-1908-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-017-1908-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-1908-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T17:02:47Z","timestamp":1554570167000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-1908-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1908"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-1908-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,7]]},"assertion":[{"value":"30 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"165"}}